Orphan designation: Omadacycline Treatment of nontuberculous mycobacterial lung disease, 25/07/2024 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 1 February 2024 - 9:00

Orphan designation: Omadacycline Treatment of nontuberculous mycobacterial lung disease, 25/07/2024 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-23-2804

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters